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INTRODUCTION
A sedentary life style can lead to an imbalance between energy intake and expenditure and favors the development of a number of chronic diseases like obesity and type 2 diabetes.
Regular exercise on the other hand is an effective way to reduce the risk for these lifestylerelated pathologies (1) . The health benefits of exercise are at least in part induced by changes in skeletal muscle tissue. Muscle cells exhibit a high plasticity and thus a remarkably complex adaptation to increased contractile activity. For example, endurance training induces mitochondrial biogenesis, increases capillary density and improves insulin sensitivity (1, 2) . To achieve such a complex plastic response, a number of different signaling pathways are activated in an exercising muscle, for example p38 MAPK-mediated protein phosphorylation events, increased intracellular calcium levels or the activation of the metabolic sensors AMP-dependent protein kinase (AMPK) and sirtuin-1 (SIRT1) (3) . While the temporal coordination of the numerous inputs is not clear, all of the major signaling pathways converge on the peroxisome proliferator-activated receptor γ coactivator 1α (PGC-1α) to either induce Ppargc1a gene expression, promote post-translational modifications of the PGC-1α protein, or by doing both (4, 5) . Upon activation, PGC-1α mediates the muscular adaptations to endurance exercise by coactivating various transcription factors (TFs) involved in the regulation of diverse biological programs such as mitochondrial biogenesis, angiogenesis, ROS detoxification or glucose uptake (3) . Accordingly, transgenic expression of PGC-1α in mouse skeletal muscle at physiological levels not only induces mitochondrial biogenesis but also drives a fiber type conversion towards a more oxidative, slow-twitch phenotype (6) while muscle-specific Ppargc1a knockout animals exhibit several symptoms of pathological inactivity (7, 8) .
Coregulators are part of multicomponent regulatory protein complexes that are well suited to translate external stimuli into changes in promoter and enhancer activities by combining various enzymatic activities to modulate histones and chromatin structure, and recruit other TFs (9) . Thus, dynamic assembly of distinct coregulator complexes enables the integration of many different signaling pathways leading to a coordinated and specific regulation of entire biological programs by multiple TFs (10, 11) . For example, PGC-1α not only recruits histone acetylases (12) , the TRAP/DRIP/Mediator (13) as well as the SWI/SNF protein complexes (14) , but also binds to and coactivates a myriad of different transcription factors, even though a systematic inventory of TF binding partners has not been compiled yet (15) . Thus, the specific control exerted by the PGC-1α-dependent transcriptional network might provide an explanation for the dynamic and coordinated muscle adaptation to exercise. Since PGC-1α in skeletal muscle not only confers a trained phenotype, but also ameliorates several different muscle diseases (16) , the unraveling of the PGC-1α-controlled transcriptional network in skeletal muscle would be of great interest to identify putative therapeutic targets within this pathway.
Therefore, we aimed at obtaining a global picture of the co-regulatory activity of PGC-1α in skeletal muscle cells. More precisely, by combining data on the genome-wide binding locations of PGC-1α and the gene expression profiles in response to PGC-1α over-expression with comprehensive computational prediction of transcription factor binding site (TFBS) occurrence, we sought to unveil the biological processes that are regulated by PGC-1α, to identify the transcription factors that partner with PGC-1α, and to determine the mechanistic details of PGC-1α-regulated transcription. We not only mapped the locations on the DNA where PGC-1α was bound, but also delineated the target genes whose expression is either directly or indirectly affected by PGC-1α and identified novel putative transcription factor partners that mediated PGC-1α's action. In particular, our results strongly suggest that the activator protein-1 (AP-1) complex is a major regulatory partner of PGC-1α, with AP-1 and PGC-1α together regulating the hypoxic response gene program in muscle cells in vitro and in vivo.
MATERIALS AND METHODS
Cell culture and siRNA transfection C2C12 cells were grown in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum (FBS), 100 Units/ml penicillin and 100ug/ml streptomycin. To obtain myotubes, the C2C12 myoblasts were allowed to reach 90% confluence and the medium was changed to DMEM supplemented with 2% horse serum (differentiation medium) for 72 hours.
The siRNAs for the knockdown of NFE2L2, FOS, JUN, ATF3, NFYC, ZFP143, GTF2I, the nontargeting siRNA pool and the DharmaFECT1 transfection reagent were purchased from Dharmacon (Fisher Scientific) and the siRNA transfection was performed according to the Thermo Scientific DharmaFECT Transfection Reagents siRNA Transfection Protocol. Briefly, after three days of differentiation, the respective siRNAs (50nM final concentration) was added to the medium. 24h after siRNA transfection, the cells were infected with either the PGC-1α or GFP adenovirus. Then, 48h after adenoviral infection, the cells were harvested. 
ChIP and ChIP Sequencing
ChIP was performed according to the Agilent Mammalian ChIP-on-chip Protocol version 10 .0. For each immunoprecipitation, approximately 1x10 8 C2C12 cells were differentiated into myotubes and infected with AV-flag-PGC-1α. For cross-linking protein complexes to DNA binding elements, the cells were incubated in a 1% formaldehyde solution for 10 minutes,
followed by the addition of glycine to a final concentration of 125mM to quench the effect of the formaldehyde. The cells were rinsed in 1xPBS, harvested in ice-cold 1xPBS using a silicone scraper and pelleted by centrifugation. The pelleted cells were either used immediately or flash frozen and stored for later. The cells were then lysed at 4°C using two lysis buffers containing 0.5% NP-40/0.25% Triton X-100 and 0.1% Na-deoxycholate/0.5% Nlauroylsarcosine, respectively. The chromatin was then sheared by sonication to obtain DNA fragments of about 100-600bp in length. 50μl of the sonicated lysate was saved as input DNA. The immunoprecipitation was performed overnight at 4°C using magnetic beads the ETH Zurich in Basel, DNA libraries were prepared using the standard Illumina ChIP-Seq protocol, as described by the manufacturer, and the immunoprecipitated samples sequenced on the Genome Analyzer II. In order to keep only high quality data, the sequenced reads were filtered based on the quality score of each read and its alignments. 
Identification of bound regions
To identify regions that were significantly enriched in the ChIP, we passed a 200 bps long sliding window along the genome, sliding by 25 bps between consecutive windows, and estimated the fraction of all ChIP reads f IP that fall within the window, as well as the fraction f WCE of reads from the whole cell extract that fall in the same window (which we estimate from a 2000 bps long window centered on the same genomic location). A Z-score quantifying the enrichment in the ChIP of each window was computed as:
where and are the variances of the IP and WCE read frequencies, which are given by: * and * respectively.
The enrichments were reproducible across biological replicates. Using only the first sequencing dataset, we called peaks at a Z cutoff of 4.5; we then compared these with the Z scores from the corresponding regions of the second dataset and the Pearson correlation coefficient was found to be 0.778. Similarly, we called peaks at a Z cutoff of 4.5 using only the second sequencing dataset; when we compared these peaks with the Z scores of the corresponding regions from the first dataset, the Pearson correlation coefficient was found to be 0.782.
To obtain a final set of binding peaks, we combined the reads from the two biological replicates computing the Z score of each window was computed as:
.
We conservatively considered all windows with a Z-score larger than 4.5 as were considered significantly enriched (False Discovery Rate 0.6%). The final binding peaks were obtained by merging consecutive windows that all passed the cut-off and by considering the "peak" to correspond to the top scoring window, i.e. corresponding to the summit of the ChIP-Seq signal. To determine the PGC-1α distribution genome-wide, peaks were annotated according in relation to their closest Mus musculus RefSeq transcripts. We defined peaks as: "Intronic"
(peak center lying inside an intron); "Exonic" (peak center lying inside an exon); "Upstream of TSS" (peak center lying within -10 to 0 kb from the closest TSS); "Downstream of TES"
(peak center lying within 0 to 10 kb from the closest TES); "Intergenic" (peak center located farer than 10 kb from the nearest transcript). Moreover, we computed the ratio between observed and expected peak location distributions, obtained by generating 100 peak sets composed of 7512 random peaks each.
Motif finding and TFBSs over-representation
The binding peak regions were aligned to orthologous regions from other 6 mammalian species -human (hg18), rhesus macaque (rheMac2), dog (canFam2), horse (equCab1), cow (bosTau3) and opossum (monDom4) -using T-Coffee (18) . A collection of 190 mammalian regulatory motifs (position weight matrices or WMs) representing the binding specificities of approximate 350 mouse TFs (in many cases, sequence specificities of multiple closely-related TFs were represented with the same WM) were downloaded from the SwissRegulon website (19) . TFBSs for all known motifs were predicted using the MotEvo algorithm (20) on the alignments of all the 7512 peak sequences. Only binding sites with a posterior probability >= 0.1 were considered for the further steps of the analysis. In order to create a background set of regions to assess the overrepresentation of binding sites within our regions, we created randomized alignments by shuffling the multiple alignment columns, maintaining both the gap patterns and the conservation patterns of the original alignments. TFBSs were predicted on the shuffled alignments using the same MotEvo settings as for the original peak alignments. Over-representation of motifs in the PGC-1α binding peaks was calculated by comparing total predicted TFBS occurrence within binding peaks with the predicted TFBS occurrence in the shuffled alignments. We evaluated the enrichment of TFBSs for each motif
x by collecting the sum of the posterior probabilities of its predicted sites in the peak alignments as well as the corresponding sum ′ in the shuffled alignments, and computed a Z-score: SVD was performed using the "svd" package of the "R" programming language.
Gene expression arrays
Whole-gene expression after 48 hours of transfection with adenovirus was measured in C2C12 cells with Affymetrix GeneChip® Mouse Gene 1.0 ST microarrays at the Life Science
Training core facility of the University of Basel. Raw probe intensities were corrected for background and unspecific binding using the Bioconductor package "affy" (21) .
Subsequently, probes were classified as expressed or non-expressed by using the "Mclust" R package (22) and, after removal of non-expressed probes, the intensity values were quantile normalized across all samples. Using mapping of the probes to the UCSC collection of mouse mRNAs, probes were then associated to a comprehensive collection of mouse promoters available from the SwissRegulon database (19) . The log2 expression level of a given promoter was calculated as the weighted average of the expression levels of all probes associated to it. Log2 expression levels were then compared between over-expressed PGC-1α and the control GFP sample; for each promoter, the change in expression level across the two conditions was measured by log2 fold change (log2FC), computed as the difference between the mean of the log2 values in PGC-1α and the mean of the log2 values in GFP. The significance of the expression change was assessed by a Z score, which was computed as:
where 3 was the number of replicate samples, is the mean log2 expression across the PGC-1α samples, is the mean log2 expression across the GFP samples, and and are the variances of log2 expression levels across the replicates for the PGC-1α
and control samples, respectively. Promoters were considered significantly up-regulated when log2FC >= 1 and Z >= 3, and significantly down-regulated when log2FC <= -1 and Z <= -
3.
Peaks were assigned to promoters by proximity. To assign each peak to a promoter, we calculated the distance from the center of the peak to the center of neighboring promoters; whenever the peak was closer than 10 kb from at least one promoter, it was assigned to the nearest promoter and, thus, to its associated gene.
Gene Ontology enrichment analysis
Gene IDs were extracted from differentially regulated promoters and divided in four groups:
up-regulated promoters with an assigned binding peak, up-regulated promoters without an assigned binding peak, down-regulated promoters with an assigned peak, and downregulated promoters without an assigned peak. These four gene sets were used as input for the functional analysis tool FatiGO (23) to identify significantly over-represented Gene Ontology (GO) categories compared to all Mus musculus genes. Only GO terms having an FDR-adjusted p-value <= 0.05 were considered significant.
Motif activity at direct and indirect targets of PGC-1α
To integrate the information from the PGC-1α binding peaks, we extended MARA (24) For each "direct target" promoter p that has an associated PGC-1α binding peak, which we defined as promoters with a peak within 1 kb or with a peak within 100 kb that was highly conserved according to PhastCons score of the region (25) For each motif we calculate both a z-score associated with its indirect activity changes, and a z-score * associated with its direct activity changes. MARA also ranks the confidence on predicted target promoters of each motif by a Bayesian procedure that quantifies the contribution of that factor to explaining the promoter's expression variation by a Chisquared value (for details, see (24)). The parameters used for motif stratification were: (i) the Z score * for direct activity changes, (ii) the Z score for indirect motif activity changes, (iii) the Z score ̅ * for direct motif activity changes, computed by averaging the sample replicates and (iv) the Z score ̅ for indirect motif activity changes, computed by averaging the sample replicates. The latter two measures were used to show which direction the motif activity changes when over-expressing PGC-1α with respect to the control condition. All motifs m for which either the direct or indirect motif activities were changing significantly ( 2) were subsequently selected.
De novo motif finding
PhyloGibbs ( The values are presented as the mean +/-SEM. A Student's t-test was performed and a pvalue < 0.05 was considered as significant (*p<0.05, **p<0.01, ***p<0.001).
Animals
Mice were housed in a conventional facility with a 12-h night/12-h day cycle with free access to chow diet pellet and water. For the experiments, 22-23 week-old skeletal muscle-specific HSA-PGC-1α knockout (MKO) male mice and 8 week-old PGC-1α muscle-specific transgenic (TG) male mice were used as previously described (6) (7) (8) . All experiments were performed according to the criteria outlined for the care and use of laboratory animals and with approval of the veterinary office of the canton Basel and the Swiss authorities.
Treadmill running
treadmill with an electric shock grid. The mice were acclimatized to the treadmill and then let run till exhaustion. The running protocol is as follows: 10m/min for 5min with an increase by 2m/min every 5min until 26m/min and an inclination of 5 degrees. The speed of 26m/min was kept until exhaustion of the mice (7, 28, 29) . Mice were killed and tissues were collected 3h after exercise.
RNA isolation of muscle tissue
Gastrocnemius and quadriceps were used to isolate RNA by TRIzol ® according to the TRIzol ® reagent RNA isolation protocol (Invitrogen).
RESULTS

Broad recruitment of PGC-1α to the mouse genome
PGC-1α-dependent gene transcription has been studied in many different experimental contexts. In isolation, gene expression arrays however are unable to distinguish direct from indirect targets, or to reveal the genomic sites where PGC-1α is recruited to enhancer and promoter elements, i.e. by coactivating TFs that directly bind to the DNA. Thus, we first In parallel to the ChIP-Seq experiment, we furthermore analyzed gene expression patterns in differentiated muscle cells both in control condition and under PGC-1α over-expression.
Using a reference set of mouse promoters (19) and associating microarray probes to promoters by mapping to known transcripts, we found 1566 promoters (corresponding to 984 genes) to be significantly up-regulated (log2 fold change >= 1; Z score >= 3) and 1165 promoters (corresponding to 727 genes) to be significantly down-regulated (log2 fold change <= -1; Z score <= -3). Thus, similar to previous reports, PGC-1α induced and repressed the transcription of almost the same number of genes, respectively, indicating that the physiological function of PGC-1α includes both the activation and inhibition of substantial numbers of genes.
To combine the DNA binding results from the ChIP-Seq with the data of the gene expression arrays, we then assigned ChIP-Seq peaks to the closest promoter (and the associated gene)
within a maximum distance of 10 kb. In this way, about 30% of all peaks (2295 of 7512) could be associated with a target promoter. Inversely, for about 35% of all significantly upregulated genes (341 of 984), a PGC-1α binding peak is found within 10 kb of the promoter.
Since some of the up-regulated promoters may be regulated by more distal peaks, this is only a lower bound on the fraction of genes that are directly regulated. In stark contrast, only about 5% of all repressed genes harbor one or more PGC-1α DNA recruitment peaks in their vicinity (36 of 727) opposed to 95% indirectly down-regulated PGC-1α target genes (691 genes) (Fig. 1D) . Moreover, the distribution of the distances between PGC-1α peaks and their associated promoters revealed a tight cluster of 532 peaks close to promoter regions for up-regulated, direct PGC-1α target genes ( Fig. 1E ) whereas the distribution of the 43 peaks associated to down-regulated genes was much wider, raising the possibility that the association of peaks to transcriptionally repressed genes might be spurious (Fig. 1F) . In summary, the strong enrichment of binding peaks near up-regulated genes and the almost complete absence of binding peaks near down-regulated genes suggest that direct regulation of transcription by PGC-1α is almost exclusively activating. We note that there is a large fraction of binding peaks (75%) that are associated to target genes that do not significantly alter their expression. These peaks may have been wrongly assigned, their functionality may be dependent on additional factors not active in these cells, or they may simply be spurious binding events that are not functional.
We next used this stratification of peaks and genes to study whether direct (i.e. with an associated binding peak) and indirect PGC-1α target genes exert different biological function and identified Gene Ontology (GO) terms that were over-represented in any of the four categories. First, we observed that the most significantly enriched functional categories for directly and indirectly up-regulated genes were those related to mitochondria, oxidative phosphorylation and energy production ( Fig. 1G and Suppl. Fig. S1B ). In contrast, GO analysis of indirectly down-regulated PGC-1α target genes revealed a high prevalence of terms related to inflammation and immune response ( Fig. 1H and Suppl. Fig. S1C ). Assuming that the assignment of peaks to repressed genes is not spurious, the few directly repressed PGC-1α targets exhibit an enrichment in functions related to muscle contraction, in particular for genes that are linked to contractile and metabolic properties of glycolytic, fast-twitch muscle fibers ( Fig. 1H and Suppl. Fig. S1D ), as would be expected from the observed shift from glycolytic to oxidative fibers mediated by PGC-1α in muscle (6) .
Modeling the direct and indirect gene regulatory effects of PGC-1α
As a next step, we rigorously modeled the effects of PGC-1α on its target genes in terms of the occurrence of TFBSs for a large collection of mammalian regulatory motifs. We previously introduced a general framework, called Motif Activity Response Analysis (MARA) (24) , for modeling the gene expression profiles as a linear function of the TFBSs occurring in the promoters and unknown regulatory "activities" of each of the regulators. As detailed in the Methods, we here extended MARA to incorporate information from the PGC-1α ChIPSeq data, with the aim of identifying which other TFs are involved in mediating both the direct and indirect regulatory effects of PGC-1α. Specifically, for all "direct target" promoters that were associated with a PGC-1α binding peak, we modeled the expression of the promoter in terms of the predicted TFBSs in the neighborhood of the binding peak, while for "indirect target" promoters we modeled the promoter's expression in terms of the predicted TFBSs in the proximal promoter region, according to the conventional MARA approach ( Fig.   2A and 2B).
First, further supporting our analysis above, direct target promoters were almost exclusively up-regulated and only in a few exceptional cases reached statistical significance for PGC-1α-repressed transcripts (Fig. 2C) . Among the direct motif activities, the ESRRA position weight matrix was the top ranking motif with a Z score of 6.04 (Suppl. Fig. 2 ). The corresponding TF estrogen-related receptor α (ERRα), an orphan nuclear receptor, has been extensively studied as a central binding partner for PGC-1α in the regulation of mitochondrial gene expression (30) (31) (32) . To stratify the different motifs according to their predicted function, we then divided all motifs into groups according to the behavior of both their direct and indirect activity changes. Strikingly, all motifs exhibited one of only four different motif activity patterns. First, 6 TFs (Suppl. Fig. S2 ) were predicted to positively regulate PGC-1α target genes only in the presence of PGC-1α (Fig. 2D) . Second, we found 6 motifs (Suppl. Fig. S2 ) with significantly up-regulated direct and indirect motif activities upon PGC-1α overexpression (Fig. 2E ). To our surprise, ERRα was predicted to regulate PGC-1α target genes in this manner, even though in previous reports gene regulation by ERRα in the context of activated PGC-1α was suggested to be dependent on PGC-1α coactivation (30) (31) (32) . Third, we found 13 motifs (Suppl. Fig. S2 ) that were predicted to regulate PGC-1α target genes, however only in the absence of PGC-1α (Fig. 2F) . Fourth, there was a group of 28 motifs (Suppl. Fig. S2 ) that showed a significant decrease of indirect motif activity upon PGC-1α over-expression, but no significant change of their direct motif activity, including NFκB (Fig.   2G ), a central regulator of inflammation which is indirectly repressed by PGC-1α (33).
Intriguingly however, no motif was found that showed significant direct repression of target genes, reinforcing the hypothesis that PGC-1α-dependent gene repression is an indirect event.
Nuclear receptors and activator protein-1-like leucine zipper proteins are the main functional partners of PGC-1α in muscle cells
As a next step, we analyzed the occurrence of TF DNA-binding motifs in the PGC-1α peaks identified by ChIP-Seq. We first performed de novo motif prediction on the top 200 peaks, using PhyloGibbs (26) . As shown in Figure 3A , the motif that PhyloGibbs identified matches significantly (E-value = 7.7834e-10, as calculated by STAMP (27) ) the canonical ESRRA motif.
In addition to the de novo prediction, we also used the same collection of 190 mammalian regulatory motifs used by MARA (19) to check which known TF DNA-binding motifs were significantly over-represented in the PGC-1α peaks relative to a set of background regions.
Many of the most significantly enriched motifs represent variations of nuclear receptor binding sequences that are based on the "AG T / G TCA" core hexamer and occur either alone or in direct, inverted or everted repeats with variable spacing (Fig. 3B ). Of these, the most significantly enriched motif was ESRRA, which is present in ~20% of all peaks. Moreover, among all genes with at least one associated binding peak within 10Kb, ~28% are associated with a peak containing a predicted ERRα site. Interestingly, besides the nuclear receptor motifs, we also found the DNA-binding element of the insulator protein CCCTC-binding factor (CTCF), and a set of highly similar DNA elements sharing the FOS-JUN-like recognition sequence "TGA G / C TCA" bound by the TFs BACH2, FOS, FOSB, FOSL1, JUN, JUNB, JUND, FOSL2, NFE2, and NFE2L2 among the top 15 motifs enriched in PGC-1α peaks (Fig. 3B ).
The identity of the exact nuclear receptor binding partner that is bound at each peak is difficult to deduce from DNA-binding motifs, since considerable promiscuity exists between receptors and DNA-binding elements in different configurations of hexameric repeats (34).
Moreover, non-nuclear receptor-like TFs are less well studied in the context of PGC-1α-controlled gene expression. Thus, to identify which regulatory motifs are most overrepresented among peaks that do not contain nuclear receptor-like sites, we first manually grouped all of the motifs with a sequence logo very similar to that of ESRRA. Next, we discarded all peaks that had one or more predicted TFBSs for any of the motifs in this set.
With the remaining 3856 DNA sequences (51.33% of the peaks), we then again assessed the over-representation of each of the 190 mammalian regulatory motifs. In this analysis, "TGA G / C TCA" recognition elements, hence FOS-JUN-like motifs, were the most significantly enriched among these peaks (Fig. 3C ). This result suggests that PGC-1α peaks naturally fall into two classes: those containing ESRRA-like sites, and those containing sites for FOS-JUNlike motifs.
We then constructed a matrix N, whose elements N pm contain the number of predicted
TFBSs for each motif m in each peak region p. We then performed principal component analysis (PCA) on this site-count matrix to identify linear combinations of regulatory motifs that explain most of the variation in site-counts across the PGC-1α peaks. The first two components (out of 190 in total) clearly proved to be the most relevant ones, accounting for 10% and 9.6 % of the total variation in our dataset, respectively (Fig. 3D) . Figure 3E The second principal component corresponds to the strength of the binding signal for these 10 motifs, as confirmed by the robust negative correlation (r=-0.92) between the TFBSs posterior sum per peak and the peak's projection along the second principal component (Fig.   3F ).
Validation of top scoring motifs reveals novel functional partners of PGC-1α
Our analysis identified a number of so-far uncharacterized TFs as potentially functional partners for PGC-1α-controlled gene expression in skeletal muscle cells. In order to experimentally validate some of these candidates, we sorted all TFs by a number of criteria including TFBS over-representation in binding peaks, MARA activity upon PGC-1α overexpression, and the expression pattern of the TFs themselves. Table 1 For each of these 7 TFs (ATF3, FOS, GTF2I, JUN, NFE2L2, NFYC and ZFP143), we selected a dozen target genes based on the Chi 2 score of the MARA prediction, presence of a PGC-1α
binding peak with at least one predicted binding site for the factor of interest, and at least a 2-fold induction upon over-expression of PGC-1α. As summarized in Fig. 4 and Suppl. Fig. S3 , siRNA-based knockdown of all TFs resulted in a robust reduction of the target mRNAs from -40% to -75%. With the exception of NFYC and JUN, we found that the large majority of predicted target genes were down-regulated upon knockdown of the factor, confirming our predictions (Fig. 4) . The most consistent effects were observed for FOS and ZFP143 (all targets down-regulated), followed by GTF2I (11 out of 12 down-regulated) and NFE2L2 and ATF3 (10 out of 12 down-regulated). Interestingly, distinct target genes of the AP-1 complex showed differential responsiveness to knockdown of the three AP-1 complex components FOS, JUN and ATF3 (Fig. 4B, Fig. 4C and Fig. 4D) . Similarly, PGC-1α-mediated induction of a majority of the predicted target genes for NFE2L2 (Fig. 4E) , ZFP143 (Fig. 4F) and GTF2I ( Fig.   4G ) was reduced upon knockdown of the respective TF when compared to the expression in cells with overexpressed PGC-1α and a scrambled siRNA control. Surprisingly, only 1 of the 11 predicted target genes for NFYC that have been chosen for validation was significantly repressed by siRNA-induced reduction of this TF (Fig. 4H) , suggesting that other TFs may be involved in mediating the regulatory effects of the NFYC regulatory motif.
Functional interaction between PGC-1α and different compositions of the AP-1 protein complex
Our targeted validation strategy revealed that PGC-1α target genes predicted to be regulated by the FOS-JUN-like motif react in distinct manners to siRNA-mediated knockdown of individual components of the AP-1 transcription factor protein complex. For example, some genes only reacted to reduction of FOS (Fig. 5A) , while others were responsive to the knockdown of two (Fig. 5B) or even all three AP-1 protein partners (Fig. 5C ) that we have tested using the siRNA-based approach. To further dissect the responsiveness of PGC-1α target genes to different AP-1 protein complexes, we performed global gene expression arrays upon knockdown of each of the three TF components of the AP-1 complex. Fig. 5D depicts the number of genes that were induced by PGC-1α and that were, at the same time, down-regulated by the siRNA knockdown of any of the three AP-1 complex members.
Amongst a total of 477 genes, 89% responded to FOS knockdown, 52% to ATF3 knockdown, and 31% to JUN knockdown. Moreover, while 37% of all targets responded exclusively to FOS, the fraction of targets responding exclusively to either JUN or ATF3 was at most 5%.
This analysis shows that, whereas different target genes respond differently to the knockdown of distinct AP-1 components, FOS is the dominant factor in determining AP-1 function in these conditions.
As shown in Fig. 3B , 341 genes were associated to a PGC-1α binding peak containing a predicted site for the FOS-JUN-like motif bound by the AP-1 complex. Of these genes, the expression of 55 was significantly induced by PGC-1α over-expression in muscle cells. In our siRNA-based validation experiment, we found that 47 out of these 55 PGC-1α-induced/AP-1 predicted targets were significantly down-regulated by knockdown of the AP-1 complex components and we called these genes "direct PGC-1α/AP-1 targets". The remaining 430 genes out of 477 (Fig. 5D) were defined accordingly as "indirect PGC-1α/AP-1 targets" that lack a PGC-1α peak containing a FOS-JUN-like motif, but still are regulated by PGC-1α and the AP-1 protein components (Fig. 5E ). To reveal whether these gene categories exert distinct functions, GO and KEGG enrichment analyses were performed. Surprisingly, the 47 direct PGC-1α/AP-1 target genes showed a distinct and significant over-representation of the terms "response to hypoxia" (GO ID: 0001666; adjusted p-value: 0.0247542) and "mTOR signaling pathway" (KEGG ID: mmu04150; adjusted p-value: 0.030674) that were absent in the GO analysis of the remaining PGC-1α/AP-1 targets (Fig. 5F ). Recruitment of FOS to the same regulatory regions as PGC-1α in the direct AP-1/PGC-1α target genes was subsequently validated by ChIP (Fig. 5G) . These results suggest that AP-1, when interacting with PGC-1α, (31, 36) . We therefore assessed the predicted and experimental overlap of these two transcription factors in the regulation of AP-1/PGC-1α target genes. Interestingly, when the PCA analysis of the PGC-1α peaks was stratified in terms of eigenpeaks, we observed two distinct groups of peaks associated with AP-1/PGC-1α target genes (Fig. 5H) .
First, some of these genes exclusively harbored peaks with FOS-JUN-like TFBSs, whereas the second group exhibited either peaks with both FOS-JUN-and ESRRA-like TFBSs, or a combination of distinct peaks with either of these sites within 10 kb from their promoters (Fig. 5H) . Next, we validated this prediction by investigating the change in expression of different AP-1/PGC-1α target genes in the context of reduced ERRα expression and function, elicited by a combination of shRNA-mediated knockdown and pharmacological treatment of muscle cells with the ERRα inverse agonist XCT790 (31) . In line with the PCA, two distinct groups of ERRα inhibition-sensitive (Fig. 5I-K ) and -insensitive (Fig. 5L-N) AP-1/PGC-1α target genes were found.
Finally, since all of the experiments were performed in differentiated myotubes in culture,
we assessed whether similar gene expression changes of the direct AP-1/PGC-1α targets involved in hypoxic gene regulation are also observed in skeletal muscle tissue of different gain-(6) and loss-of-function mouse models (7, 8) in vivo. In skeletal muscle-specific PGC-1α knockout mice, the expression of several of these genes was reduced significantly (Fig. 6A-F) .
Surprisingly however, some of the predicted transcripts were not altered in this loss-offunction model for PGC-1α, for example Nr0b2 (Fig. 6E) . To further clarify the role of PGC-1α in the regulation of these genes, relative transcript levels were next assessed in musclespecific transgenic mice for PGC-1α (Fig. 6G-L) . In most cases, the genes with a reduction in their transcription in the PGC-1α muscle-specific knockout animals were inversely elevated in the PGC-1α muscle-specific transgenic mice. Moreover, some of these genes were likewise induced by exercise (Fig. 6G-L ) and at least in some cases, for example Twf2 and Nr0b2 ( Fig.   6J and K), PGC-1α overexpression and physical activity synergistically boosted gene expression, for Nr0b2even in the absence of any effect of the muscle-specific PGC-1α transgene per se (Fig. 6K) .
DISCUSSION
Exercise-induced skeletal muscle cell plasticity is a highly complex biological program that involves the remodeling of a number of fundamental cellular properties. Since PGC-1α function has been strongly linked to the induction of an endurance-trained muscle phenotype, we here dissected the PGC-1α-controlled transcriptional network in muscle cells.
First, our results reveal a broad recruitment of PGC-1α to many different sites in the mouse genome (7512 peaks), the majority of which were either not located within 10 kb distance from a promoter or close to a gene that was not regulated by PGC-1α over-expression at the time of harvest of the cells, as has analogously been observed in many other ChIP-Seq experiments (for example, see ref. 37 ). Apart from the fact that PGC-1α could mediate longrange enhancer effects that were excluded in our peak-gene assignment, it is conceivable that PGC-1α recruitment is transcriptionally silent in some binding peaks because it requires the recruitment of additional cofactors for activation, which are not present in the conditions or cell type in which our experiments were performed. In addition, it is possible that a large fraction of PGC-1α binding peaks may be "neutral" in the sense of not having any direct role in regulating gene expression.
Second, while an almost equally strong effect of PGC-1α on gene induction and repression has been reported (31), our analysis now indicates that direct PGC-1α-mediated gene expression is restricted almost exclusively to positively regulated PGC-1α target genes, whereas the vast majority of gene repression is indirect, i.e. not associated with PGC-1α recruitment within a 10 kb distance to their promoters. Thus, the fact that almost 95% of all repressed genes were not linked to PGC-1α recruitment strongly implies that this coregulator primarily acts as a coactivator, and not as a corepressor as suggested by the data of some studies (38) (39) (40) . Importantly, indirect repression of PGC-1α target genes was also supported by the MARA prediction. The strong indirect inhibition of genes, many of which are involved in inflammatory processes, is predicted by MARA to be mediated by TFs such as NFκB and IRF factors. Such an indirect inhibition of NFκB and pro-inflammatory genes by PGC-1α in muscle cells has been reported previously (33) .
One of the main functions of PGC-1α in all cells and organs is to boost mitochondrial gene transcription and oxidative metabolism. Accordingly, we observed that Gene Ontology terms related to these pathways were highly enriched when analyzing positively regulated PGC-1α target genes in muscle cells. Based on previous studies, the regulation of this core function could have been assigned to the direct interaction of PGC-1α and ERRα binding to regulatory elements of these genes (31, 32) . Surprisingly, our data indicate that many of the genes that are involved in oxidative metabolic pathways are indirectly controlled by PGC-1α and, hence, do not require PGC-1α recruitment to enhancer and promoter elements. Likewise unexpectedly, the MARA analysis implies ERRα action on direct and indirect PGC-1α-induced target genes, i.e. in the presence or absence of PGC-1α coactivation. Thus, while these observations might obviously reflect a temporally distinct control of different PGC-1α target genes that is not represented in our simultaneous analysis of DNA binding and gene expression at one time point, it is conceivable that PGC-1α acts primarily as an upstream regulator of other factors that are subsequently controlling more downstream PGC-1α target genes without direct involvement of PGC-1α itself.
In skeletal muscle, PGC-1α has been reported to interact with ERRs, PPARs and other nuclear receptors, as well as myocyte enhancer and nuclear respiratory factors to mediate transcriptional regulation (3). Accordingly, ERRα and other nuclear receptor binding motifs were amongst the most highly significant binding elements in our present report.
Importantly however, we also predict a number of so-far unknown TFs to functionally interact with PGC-1α and thereby contribute to PGC-1α-controlled gene expression in skeletal muscle. Since a complete functional validation of all new putative TF partners is beyond the scope of this manuscript, we combined the high-throughput results with several computational analyses (see Table 1 
AP-1 function itself is regulated by a variety of stimuli, including cytokines, growth factors
and stress, and subsequently controls a number of cellular processes including apoptosis, cell proliferation and differentiation, stress response and hypoxia (41, 42) . Mechanistically, we classified PGC-1α-induced/AP-1-knocked-down targets in either direct or indirect genes.
Most interestingly, functional analysis of these two groups of genes revealed that when AP-1 and PGC-1α act disjointedly, they are involved in the regulation of mitochondrial and other metabolic genes while, when coactivated by PGC-1α, AP-1 distinctly alters the expression of genes that are enriched in the ontology terms "response to hypoxia" and "mTOR signaling" (Fig. 5F ). Intriguingly, a closer analysis of all 47 direct AP-1/PGC-1α target genes revealed 24 genes that are induced by hypoxia, are effectors of hypoxia or attenuate the detrimental consequences of hypoxia (Fig. 6M ). For example, several inhibitors of the mTOR signaling pathways are included in this group of genes and hypoxia has been described as a suppressor of mTORC1 activity (43) . Another group of genes contributes to the reduction of cellular stress, detrimental metabolites, reactive oxygen species and increase in cellular survival to reduce potential harmful consequences of prolonged hypoxia (44) . Furthermore, several genes promote endothelial regeneration, vascular remodeling and vascularization (45) . In this context, PGC-1α has previously been shown to promote VEGF-induced angiogenesis in skeletal muscle in a hypoxia-inducible factor 1α (HIF-1α)-independent, ERRα-dependent manner (36) . Similarly, PGC-1α regulates the hypoxic response of brown fat (46) remodeling protein complexes, a scenario can thus be conceived in which PGC-1α is able to control and integrate different signaling pathways using a multitude of different transcription factor binding partners (10, 11) . A better understanding of such regulatory networks will eventually allow the targeting of whole biological programs or specific submodules in pathological states of disregulation.
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